1H-피롤로[2,3-c]피리딘계 화합물 및 이의 용도

본 발명은 일련의 1H-피롤로[2,3-c]피리딘계 화합물 및 이의 용도, 구체적으로 식 (P)로 표시되는 화합물 및 이의 약학적으로 허용 가능한 염을 개시한다: JPEGpct00141.jpg2563 A series of 1H-pyrrolo[2,3-c]pyridine compounds and an application thereof, specifically disclosed are compounds represented by formula (P) and a pharmaceutically acceptable salt thereof....

Full description

Saved in:
Bibliographic Details
Main Authors YANG CHUNDAO, CHEN SHUHUI, QIAN WENYUAN, WEI XIAWEI, XU GUANGHAI, JIANG NING
Format Patent
LanguageKorean
Published 02.05.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract 본 발명은 일련의 1H-피롤로[2,3-c]피리딘계 화합물 및 이의 용도, 구체적으로 식 (P)로 표시되는 화합물 및 이의 약학적으로 허용 가능한 염을 개시한다: JPEGpct00141.jpg2563 A series of 1H-pyrrolo[2,3-c]pyridine compounds and an application thereof, specifically disclosed are compounds represented by formula (P) and a pharmaceutically acceptable salt thereof.
AbstractList 본 발명은 일련의 1H-피롤로[2,3-c]피리딘계 화합물 및 이의 용도, 구체적으로 식 (P)로 표시되는 화합물 및 이의 약학적으로 허용 가능한 염을 개시한다: JPEGpct00141.jpg2563 A series of 1H-pyrrolo[2,3-c]pyridine compounds and an application thereof, specifically disclosed are compounds represented by formula (P) and a pharmaceutically acceptable salt thereof.
Author YANG CHUNDAO
WEI XIAWEI
CHEN SHUHUI
JIANG NING
QIAN WENYUAN
XU GUANGHAI
Author_xml – fullname: YANG CHUNDAO
– fullname: CHEN SHUHUI
– fullname: QIAN WENYUAN
– fullname: WEI XIAWEI
– fullname: XU GUANGHAI
– fullname: JIANG NING
BookMark eNrjYmDJy89L5WSwNvTQfTtlz-uFS14vnBNtpGOsmxwL4i9b83rKjFebWxTezpzydurK12v2KLze0K_wZu6WN3NnKLyZtfJ1fwsPA2taYk5xKi-U5mZQdnMNcfbQTS3Ij08tLkhMTs1LLYn3DjIyMDI2MDC1MDQ2cTQmThUApIw_Rw
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID KR20230058134A
GroupedDBID EVB
ID FETCH-epo_espacenet_KR20230058134A3
IEDL.DBID EVB
IngestDate Fri Aug 16 05:46:31 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Korean
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_KR20230058134A3
Notes Application Number: KR20237010477
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230502&DB=EPODOC&CC=KR&NR=20230058134A
ParticipantIDs epo_espacenet_KR20230058134A
PublicationCentury 2000
PublicationDate 20230502
PublicationDateYYYYMMDD 2023-05-02
PublicationDate_xml – month: 05
  year: 2023
  text: 20230502
  day: 02
PublicationDecade 2020
PublicationYear 2023
RelatedCompanies JUMBO DRUG BANK CO., LTD
RelatedCompanies_xml – name: JUMBO DRUG BANK CO., LTD
Score 3.4446263
Snippet 본 발명은 일련의 1H-피롤로[2,3-c]피리딘계 화합물 및 이의 용도, 구체적으로 식 (P)로 표시되는 화합물 및 이의 약학적으로 허용 가능한 염을 개시한다: JPEGpct00141.jpg2563 A series of 1H-pyrrolo[2,3-c]pyridine compounds...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title 1H-피롤로[2,3-c]피리딘계 화합물 및 이의 용도
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230502&DB=EPODOC&locale=&CC=KR&NR=20230058134A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTdOSQXWpKm6ycASWBdYBSTrWpimmusC6x5jo7SkJLNEY9BuZF8_M49QE68I0wgmhhzYXhjwOaHl4MMRgTkqGZjfS8DldQFiEMsFvLayWD8pEyiUb-8WYuuiBu0dA9vTpgZGai5Otq4B_i7-zmrOzrbeQWp-QRA5A1MLQ2MTR2YGVlBDGnTSvmuYE2hfSgFypeImyMAWADQvr0SIgSk7X5iB0xl295owA4cvdMobyITmvmIRBmtDD923U_a8Xrjk9cI50UY6xrrJsSD-sjWvp8x4tblF4e3MKW-nrny9Zo_C6w39Cm_mbnkzd4bCm1krX_e3iDIou7mGOHvoAl0RD_d0vHcQspONxRhY8vLzUiUYFFKBnQjDFBNTi2RjIGlsZpFmCWQYmaYmmZhbppgZSTLI4DNJCr-0NAMXiAte0mckw8BSUlSaKgusdkuS5MChBQCmCpL5
link.rule.ids 230,309,786,891,25594,76904
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTdOSQXWpKm6ycASWBdYBSTrWpimmusC6x5jo7SkJLNEY9BuZF8_M49QE68I0wgmhhzYXhjwOaHl4MMRgTkqGZjfS8DldQFiEMsFvLayWD8pEyiUb-8WYuuiBu0dA9vTpgZGai5Otq4B_i7-zmrOzrbeQWp-QRA5A1MLQ2MTR2YGVnNgpxB00r5rmBNoX0oBcqXiJsjAFgA0L69EiIEpO1-YgdMZdveaMAOHL3TKG8iE5r5iEQZrQw_dt1P2vF645PXCOdFGOsa6ybEg_rI1r6fMeLW5ReHtzClvp658vWaPwusN_Qpv5m55M3eGwptZK1_3t4gyKLu5hjh76AJdEQ_3dLx3ELKTjcUYWPLy81IlGBRSgZ0IwxQTU4tkYyBpbGaRZglkGJmmJpmYW6aYGUkyyOAzSQq_tDwDp0eIr0-8j6eftzQDF0gKvLzPSIaBpaSoNFUWWAWXJMmBQw4ArFSV5A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=1H-%ED%94%BC%EB%A1%A4%EB%A1%9C%5B2%2C3-c%5D%ED%94%BC%EB%A6%AC%EB%94%98%EA%B3%84+%ED%99%94%ED%95%A9%EB%AC%BC+%EB%B0%8F+%EC%9D%B4%EC%9D%98+%EC%9A%A9%EB%8F%84&rft.inventor=YANG+CHUNDAO&rft.inventor=CHEN+SHUHUI&rft.inventor=QIAN+WENYUAN&rft.inventor=WEI+XIAWEI&rft.inventor=XU+GUANGHAI&rft.inventor=JIANG+NING&rft.date=2023-05-02&rft.externalDBID=A&rft.externalDocID=KR20230058134A